推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-33632861

chinasupport@letpub.com

登录 注册 新注册优惠

TUMOR BIOLOGY

2023年12月最新中科院分区表数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

按期刊名首写字母查看 TUMOR BIOL最新评论:方法的书写原则就是提供足够的实验信息让同行重复实验过程。实验需要的指标以及程序应当描述全面规范。 (2021-12-30)


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中科院分区:   是否OA期刊:   结果排序:

同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看:


TUMOR BIOLOGY期刊基本信息Hello,您是该期刊的第97460位访客

基本信息 登录收藏
期刊名字TUMOR BIOLOGYTUMOR BIOLOGY

TUMOR BIOL
(此期刊未被最新的JCR期刊引证报告收录)

LetPub评分
4.0
50人评分
我要评分

声誉
3.7

影响力
3.1

速度
9.1

期刊ISSN1010-4283
微信扫码收藏此期刊
E-ISSN1423-0380
2022-2023最新影响因子
(数据来源于搜索引擎)
0 点击查看影响因子趋势图
实时影响因子 -
2022-2023自引率N.A.点击查看自引率趋势图
五年影响因子0
h-index 70
CiteScore
CiteScoreSJRSNIPCiteScore排名
5.400.6450.808
学科分区排名百分位
大类:Biochemistry, Genetics and Molecular Biology
小类:Cancer Research
Q3115 / 214

期刊简介Tumor Biology is a peer reviewed, international journal providing an open access forum for experimental and clinical cancer research. Tumor Biology covers all aspects of tumor markers, molecular biomarkers, tumor targeting, and mechanisms of tumor development and progression.

Specific topics of interest include, but are not limited to:

Pathway analyses,
Non-coding RNAs,
Circulating tumor cells,
Liquid biopsies,
Exosomes,
Epigenetics,
Cancer stem cells,
Tumor immunology and immunotherapy,
Tumor microenvironment,
Targeted therapies,
Therapy resistance
Cancer genetics,
Cancer risk screening.
Studies in other areas of basic, clinical and translational cancer research are also considered in order to promote connections and discoveries across different disciplines.

The journal publishes original articles, reviews, commentaries and guidelines on tumor marker use. All submissions are subject to rigorous peer review and are selected on the basis of whether the research is sound and deserves publication.

Tumor Biology is the Official Journal of the International Society of Oncology and BioMarkers (ISOBM).
期刊官方网站https://www.springer.com/journal/13277
期刊投稿网址https://www.editorialmanager.com/TUBI
期刊语言要求Language
Presenting your work in a well-structured manuscript and in well-written English gives it its best chance for editors and reviewers to understand it and evaluate it fairly. Many researchers find that getting some independent support helps them present their results in the best possible light.

经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足TUMOR BIOLOGY的语言要求,还能让TUMOR BIOLOGY编辑和审稿人得到更好的审稿体验,让稿件最大限度地被TUMOR BIOLOGY编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢
提交文稿
是否OA开放访问Yes
OA期刊相关信息
文章处理费:需要( USD2000; )
文章处理费豁免:查看说明

其他费用:没有
期刊主题关键词:molecular biomarkers、tumour markers、tumour targetting
相关链接:Aims & ScopeAuthor InstructionsEditorial BoardBlind peer review
通讯方式SPRINGER, VAN GODEWIJCKSTRAAT 30, DORDRECHT, NETHERLANDS, 3311 GZ
出版商Springer Netherlands
涉及的研究方向医学-肿瘤学
出版国家或地区SWITZERLAND
出版语言English
出版周期Bimonthly
出版年份2010
年文章数 1625点击查看年文章数趋势图
Gold OA文章占比0.00%
研究类文章占比:
文章 ÷(文章 + 综述)
0.00%
WOS期刊SCI分区
2022-2023年最新版
WOS分区等级:0区

暂无按学科分区信息
中科院《国际期刊预警
名单(试行)》名单
2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
中科院SCI期刊分区
2023年12月最新升级版
点击查看中科院SCI期刊分区趋势图
(没有被最新的JCR升级版收录,仅供参考)
中科院SCI期刊分区
2022年12月升级版
(没有被2022年的JCR升级版收录,仅供参考)
中科院SCI期刊分区
2021年12月旧的升级版
(没有被旧的JCR升级版收录,仅供参考)
SCI期刊收录coverage Scopus (CiteScore)
Directory of Open Access Journals (DOAJ)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1010-4283%5BISSN%5D
平均审稿速度网友分享经验:
平均1.0个月
平均录用比例网友分享经验:
约27.5%
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在TUMOR BIOLOGY顺利发表。
快看看作者怎么说吧:服务好评 论文致谢
期刊常用信息链接
同领域相关期刊 TUMOR BIOLOGY期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 TUMOR BIOLOGY中科院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
TUMOR BIOLOGY上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中科院SCI期刊分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发表论文
  • 中科院SCI期刊分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144642.90
    Nature Reviews Clinical Oncology12775.50
    NATURE REVIEWS CANCER39696.70
    LANCET ONCOLOGY27462.00
    ANNALS OF ONCOLOGY21063.00
    CANCER CELL29552.90
    JOURNAL OF CLINICAL ONCOLOGY49439.60
    SEMINARS IN CANCER BIOLOGY13420.00
    CANCER TREATMENT REVIEWS11620.70
    CLINICAL CANCER RESEARCH29221.80
    中科院SCI期刊分区同大类学科的热搜期刊 浏览次数
    此期刊未被最新的JCR收录
  •  

    TUMOR BIOLOGY TUMOR BIOLOGY
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.Circulating tumor-associated neutrophils (cTAN) contribute to circulating tumor cell survival by suppressing peripheral leukocyte activation

    Author: Juechao Zhang, Xuan Qiao, Huifang Shi, Xiaoqing Han, Wenguang Liu, Xiujuan Tian, Xianlu Zeng
    Journal: TUMOR BIOLOGY, 2015, Vol.37, 5397-5404, DOI:10.1007/s13277-015-4349-3
        DOI
    2.Polymorphisms in epidermal growth factor receptor (EGFR) and AKT1 as possible predictors of clinical outcome in advanced non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitors

    Author: Xiaoqing Zhang, Junwei Fan, Yuping Li, Shengtao Lin, Ping Shu, Jian Ni, Shengying Qin, Zhemin Zhang
    Journal: TUMOR BIOLOGY, 2015, Vol.37, 1061-1069, DOI:10.1007/s13277-015-3893-1
        DOI
    3.The effect of antisense inhibitor of miRNA 106b∼25 on the proliferation, invasion, migration, and apoptosis of gastric cancer cell

    Author: Rupeng Zhang, Fangxuan Li, Weijia Wang, Xuejun Wang, Shixia Li, Juntian Liu
    Journal: TUMOR BIOLOGY, 2016, Vol.37, 10507-10515, DOI:10.1007/s13277-016-4937-x
        DOI
    4.Imperatorin acts as a cisplatin sensitizer via downregulating Mcl-1 expression in HCC chemotherapy

    Author: Jianjian Hu, Changlong Xu, Bihuan Cheng, Lingxiang Jin, Jie Li, Yuqiang Gong, Wei Lin, Zhenzhen Pan, Chenwei Pan
    Journal: TUMOR BIOLOGY, 2015, Vol.37, 331-339, DOI:10.1007/s13277-015-3591-z
        DOI
    5.Diagnostic significance of S100A2 and S100A6 levels in sera of patients with non-small cell lung cancer

    Author: Ting Wang, Yiqian Liang, Asmitananda Thakur, Shuo Zhang, Tian Yang, Tianjun Chen, Lei Gao, Mingwei Chen, Hui Ren
    Journal: TUMOR BIOLOGY, 2015, Vol.37, 2299-2304, DOI:10.1007/s13277-015-4057-z
        DOI
    6.Wnt5a and Ror2 expression associate with the disease progress of primary thyroid lymphoma

    Author: Lei Wang, Dong Yang, Ying-Hou Wang, Xi Li, Hong-Ming Gao, Jun-Yuan Lv, Lei Wang, Shi-Jie Xin
    Journal: TUMOR BIOLOGY, 2015, Vol.37, 6185-6190, DOI:10.1007/s13277-015-4470-3
        DOI
    7.Isocitrate dehydrogenase 2 inhibits gastric cancer cell invasion via matrix metalloproteinase 7

    Author: Dandan Wu
    Journal: TUMOR BIOLOGY, 2015, Vol.37, 5225-5230, DOI:10.1007/s13277-015-4358-2
        DOI
    8.Wnt5a and Ror2 expression associate with the disease progress of primary thyroid lymphoma

    Author: Lei Wang, Dong Yang, Ying-Hou Wang, Xi Li, Hong-Ming Gao, Jun-Yuan Lv, Lei Wang, Shi-Jie Xin
    Journal: TUMOR BIOLOGY, 2015, Vol.37, 6085-6090, DOI:10.1007/s13277-015-4471-2
        DOI
    9.The clinical and biological significance of MICA in clear cell renal cell carcinoma patients

    Author: Xiang Zhang, Lei Yan, Wei Jiao, Juchao Ren, Naidong Xing, Yongzhen Zhang, Yuanwei Zang, Jue Wang, Zhonghua Xu
    Journal: TUMOR BIOLOGY, 2015, Vol.37, 2153-2159, DOI:10.1007/s13277-015-4041-7
        DOI
    10.U/G SNP rs111904020 in 3′UTR of STAT3 regulated by miR-214 promotes hepatocellular carcinoma development in Chinese population

    Author: Ye Fan, Xiaofeng Qian, Chuanyong Zhang
    Journal: TUMOR BIOLOGY, 2016, Vol.37, 14629-14635, DOI:10.1007/s13277-016-5352-z
        DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    此期刊未被最新的JCR收录
    同分区等级的其他期刊名称 h-index CiteScore
    此期刊未被最新的JCR收录


以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:

    同领域作者分享投稿经验:共723条 (包含回复)

我来分享

    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2024 中国: LetPub上海分公司    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960

    增值电信业务经营许可证:沪B2-20211595

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室

    United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451